Skip to content

13F-HR filed by HHLR ADVISORS, LTD.

HHLR ADVISORS, LTD. filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-15, with 30 holding rows worth $3,589,848,000.

Accession
0000902664-19-002354
Filed
2019-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2019

A holdings report, 30 entries on the cover page, a total value of $3,589,848,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,589,848,000 with VALUE read as thousands by filing date, 13F file number 028-19395. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR4,437,953$585,810,000thousands by filing date
JD.COM INC SPON ADS CL A47215P106ADR15,041,243$453,493,000thousands by filing date
TAL ED GROUP SPONSORED ADS874080104ADR11,410,453$411,689,000thousands by filing date
IQIYI INC SPONSORED ADS46267X108ADR12,557,488$300,375,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS1,411,830$257,588,000thousands by filing date
CHINA BIOLOGIC PRODS HLDGS IG21515104COM2,751,200$251,047,000thousands by filing date
META PLATFORMS INC CL A30303M102COM1,179,600$196,628,000thousands by filing date
Mondelez International,Inc. Class A609207105COM3,014,473$150,482,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM1,498,516$119,956,000thousands by filing date
FIBROGEN INC31572Q808COM2,003,287$108,879,000thousands by filing date
SEA LTD81141R100SPONSORD ADS4,300,000$101,136,000thousands by filing date
MELCO RESORTS & ENTERTAINMENT585464100ADR4,395,700$99,299,000thousands by filing date
ENSTAR GROUP LIMITEDG3075P101SHS543,487$94,567,000thousands by filing date
PDD HOLDINGS INC SPONSORED ADS722304102ADR3,132,096$77,676,000thousands by filing date
BILIBILI INC SPONS ADS REP Z090040106ADR3,452,231$65,420,000thousands by filing date
MYOKARDIA INC62857M105COM975,987$50,742,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM2,579,708$50,304,000thousands by filing date
LINE CORP53567X101SPONSORED ADR1,207,763$42,525,000thousands by filing date
BRIGHT SCHOLAR ED HLDGS LTD109199109SPONSORED ADS3,985,797$41,213,000thousands by filing date
KINIKSA PHARMACEUTICALS LTDG5269C101COM CL A1,835,888$33,156,000thousands by filing date
TENCENT MUSIC ENTMT GROUP SPON ADS88034P109ADR1,470,491$26,616,000thousands by filing date
GOSSAMER BIO INC COM38341P102Stock937,500$20,316,000thousands by filing date
G1 THERAPEUTICS INC3621LQ109COM949,431$15,761,000thousands by filing date
Sohu.Com Ltd-Adr83410S108COM802,034$13,298,000thousands by filing date
ARVINAS INC04335A105COM625,000$9,225,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM425,000$5,308,000thousands by filing date
EIDOS THERAPEUTICS INC.28249H104Common Stock178,600$4,188,000thousands by filing date
FANG HOLDING-ADR30711Y102ADR1,500,000$2,025,000thousands by filing date
PUXIN LTD74704P108ADS126,145$874,000thousands by filing date
NEW ORIENTAL EDUCATION & TECHN647581107SPON ADR2,800$252,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000902664-19-002354this filing2019-05-15acceptance time not in the bulk data set